A batch of stock rights concentrate on being listed and transferring Department's stock right of traditional Chinese medicines adjusts and works for moving

A batch of stock rights concentrate on being listed and transferring Department's stock right of traditional Chinese medicines adjusts and works for moving
Recently, holding 1% of the stock rights of state congress dispensary traditional Chinese medicines under the medical group head office of China, Shanghai medical equipment Co., Ltd. 20.4% stock right and the intersection of traditional Chinese medicines and the intersection of group and the intersection of country and auspicious the intersection of Pharmaceutcal Co., Ltd. and the intersection of 1.69% stock right,etc. and stock right centre in Shanghai stock exchange list and transfer publicly. It is said, this is carried on on the basis that group's stock right of traditional Chinese medicines adjust the overall plan requirement.
Among them, holding 1% of the stock rights of state congress dispensary Co., Ltd. traditional Chinese medicines are listed with 2,152,400 yuan. It sells to be a China medical group head office ' Abbreviated as the traditional Chinese medicines group) With the commercial assets management Co., Ltd. of Zhabei district of Shanghai, the shareholding ratio of the two, respectively in order to hold 0.25% and 0.75% shares.
The materials reveal, state congress dispensary was established in March of 2004, total assets were 375,720,700 yuan in 2008, net profit - 1,707,000 yuan in January - November of this year, the net profit will be - 3,371,200 yuan in 2008, it is 6,371,600 yuan in 2007. The net assets will be 186,862,100 yuan by December 31, 2008, assessing value is 215,240,000 yuan. Traditional Chinese medicines which are held the 99% of the stock rights of this target control interest to show, do not give up exercising purchase preference.
In addition, 1.69% of the stock rights of auspicious Pharmaceutcal Co., Ltd. of country of traditional Chinese medicines group are listed and transfer with 2,035,500 yuan. It is medical equipment Co., Ltd. of the health in traditional Chinese medicines of Beijing to sell, cure Chinese company's subsidiary of medical equipment industry of the group for the country. This target holds 98.31% of the subsidiaries shares for the traditional Chinese medicines share. However, the traditional Chinese medicines share shows that give up exercising purchase preference. This target is by December 31, 2008, the net assets of book are 71,596,000 yuan, assessing value is 120,443,500 yuan.
In addition, Shanghai Company of traditional Chinese medicines group is also listed and transferred 20.4% of the stock rights of Shanghai medical equipment Co., Ltd. of traditional Chinese medicines group with 1,628,600 yuan. Hold, unite medical equipment Co., Ltd., say that give up purchase preference by 79.6% the intersection of traditional Chinese medicines and group of share separately.
As to the stock right grantee, the net assets are not lower than 1,500 million yuan by December 31, 2008 except the extra demand which the auspicious medicine company in the country marks, the others must require the grantee for state-owned and state holding enterprises, have made profits, has more than 5 years has been engaged in medical trade experience etc. for two years in succession from 2007 to 2008.
Yesterday, real medicine and recombination scheme of Chinese and Western medicine were checked on the medical merger of Shanghai that was had ready conditions to pass by the SFC. Insider point out having the income approaches 30 billion yuan this year such as medicine while being new combine, in addition, will be implemented in an all-round way annually by the new medical reform in 2010, every large medical group will enter and expand one fast, these factor or forcing the traditional Chinese medicines department to combine.
The materials reveal, group established traditional Chinese medicines on November 26, 1998, it was by the largest medical enterprise group of our country taking medical scientific research, production and service trade as staple of central management, there are traditional Chinese medicines in listed companies such as holding and traditional Chinese medicines share, unanimous medicine company,etc. under command. The income from sales is 37,300 million yuan in 2007, import-export volume is 770 million dollars.
|